In recent years, the antifungal drug ciclopirox olamine (CPX) has been repositioned as an anticancer drug, and the mechanism of CPX in treating colorectal cancer has also been elucidated: the downregulation of DJ-1 is the key mechanism for the anticancer activity of CPX (52). This evidence concerns the gene PARK7 and colorectal cancer.